Novavax (NVAX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 -1.42%
EPS Growth %: -164.5%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -164.5%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $8.03 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
